Stocks Reviews

The company Oracle (ORCL) reported that their profit exceeded analysts’ predictions despite the fact that the company increased expenses on software creation – databases and applications that are helping it run its business. Oracle’s first quarter profit, excluding some points of the financial report, was 48 cents per share, exceeding the average prediction of 47 cents per share. Sales increased 12% to $8.37 billion, coinciding with analysts’ predictions. Oracle’s CEO Larry Ellison continues to benefit from more than $40 billion of mergers and acquisitions since 2005. These acquisitions added several programs to Oracle’s arsenal which are helping the giant corporation manage operations and solve complex computational problems. The income helped the company close the second quarter in a row with increased profit despite decreased sales of machinery and devices. The DT Trading Analytical Department thinks that the company’s optimized expenses during the escalating crisis and drop in production will help the company develop further given its decent profit figures. Oracle is...

Some of the stocks that may grab investor focus today are: Wall Street expects American Express Company (NYSE: AXP) to report its Q2 EPS at $0.98 on revenue of $7.35 billion. AXP shares gained 0.37% to $52.00 in after-hours trading. Apple Inc (NASDAQ: AAPL) reported upbeat quarterly results. Apple sold 20.34 million iPhones during the quarter, versus an estimated 17 million to 18 million. Apple's net income in the fiscal third quarter surged to $7.31 billion, or $7.79 per share, from $3.25 billion, or $3.51 per share, in the year-ago period. Its revenue jumped 82% y/y to $28.6 billion, from $15.7 billion. Analysts were expecting earnings of $5.82 per share on revenue of $24.8 billion. Apple shares jumped 4.55% to $394.00 in the after-hours trading session. Analysts are expecting Abbott Laboratories (NYSE: ABT) to have earned $1.11 per share on revenue of $9.56 billion in the second quarter. ABT shares rose 0.67% to close at $52.89 yesterday. Yahoo! Inc (NASDAQ: YHOO) reported its Q2...

US stock futures are higher this morning, as investors are awaiting quarterly earnings from major companies. Futures on the Dow Jones Industrial Average surged 71 points to 12,399.00 and futures on the S&P 500 stock index rose 8.30 points to 1,308.70. Nasdaq 100 futures gained 15.75 points to 2,355.75. US stocks closed lower on Monday, with the Dow Jones industrial average dropping 0.76% to 12,385.16, the broader Standard & Poor's 500 index declining 0.81% to 1,305.44 and the NASDAQ composite index dipping 0.89% to 2,765.11. Data on housing starts for June will be released at 8:30 a.m. ET. International Business Machines Corp (NYSE: IBM) reported its Q2 profit at $3.66 billion, or $3 per share, up from $3.39 billion, or $2.61 per share, in the year-ago quarter. Its revenue surged 12% to $26.7 billion. However, analysts were expecting earnings of $3.03 per share on revenue of $25.35 billion. The company also lifted its earnings forecast for the full year. Harley-Davidson Inc (NYSE: HOG) is...

Harley-Davidson Inc (NYSE: HOG) reported a strong rise in its second-quarter net income and lifted its forecast of shipments for the full year. HOG's quarterly profit increased to $190.6 million, or $0.81 per share, from $71.2 million, or $0.30 per share, in the year-ago quarter. Its revenue climbed 18% to $1.3 billion. Its profit from continuing operations came in at $0.81 per share. Analysts were expecting earnings of $0.72 per share on revenue of $1.26 billion. HOG now projects to ship 228,000 to 235,000 motorcycles in 2011, versus its April forecast of 215,000 to 228,000 bikes. Coca-Cola Co (NYSE: KO) reported an 18% rise in its second-quarter profit. KO's quarterly profit surged to $2.8 billion, or $1.20 per share, from $2.37 billion, or $1.02 per share, in the year-earlier quarter. Its revenue climbed 47% y/y to $12.74 billion from $8.67 billion. Analysts were expecting earnings of $1.15 per share on revenue of $12.39 billion. Goldman Sachs Group Inc (NYSE: GS) reported downbeat...

Cisco Systems (NASDAQ: CSCO) provided additional detail Monday about its plans to reduce its global workforce by 6,500 employees - part of an effort to save $1 billion in annual operating expenses. The reduction would equate to 9% of Cisco's regular full-time employees. The technology company has challenged itself to cut costs in a difficult operating environment, echoing a similar measure by Goldman Sachs (NYSE: GS) to save $1 billion. The Cisco plan "includes approximately 2,100 employees who elected to participate in a voluntary early retirement program. This also includes a reduction totaling approximately 15 percent of vice president level and above employees." Investors in Cisco have been punished in the past 14 months. Since the Spring of 2010, when the stock was above $25, shares have fallen to just above $15. Cisco expects that it will recognize total pre-tax restructuring charges to its GAAP financial results of $1.3 billion over several quarters. Cisco also announced Monday an agreement for sale of its set-top box...

On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Sonic Automotive (NYSE: SAH) is a “great buy.” He added, “AutoZone (NYSE: AZO) has been great, Carmax (NYSE: KMX) has been great and Sonic Automotive is good, too. I think they're fabulous investments." For TIBCO Software (NASDAQ: TIBX), he said, "Here's the problem: I can't recommend tech in the summer. I like the company but these stocks get beat up every day. There will be a better price in August." Cramer said, “I'm not into Orbitz Worldwide (NYSE: OWW). They restructured, but I'd rather be in Travelzoo (NASDAQ: TZOO). I wouldn't buy TravelZoo up $7 today, but on a pullback, I like it." For Telefonica (NYSE: TEF), Jim said, "No, I'm not going to Spain. It's too dicey. I'd go with Vodafone Group (NASDAQ: VOD) for that yield." He said, "It's hard to do better than MarkWest Energy Partners (NYSE: MWE). That's a stock I want you to own." For Krispy Kreme Doughnuts...

Medidata Solutions (MDSO) analysts moved their forecasts higher after the last quarterly report, pushing shares to a Zacks #1 Rank (Strong Buy). The company is also active in the M&A market and trades with solid valuations. Company Description Medidata Solutions provides software services used by life science groups in clinical development. Record-Setting Quarter On May 10 Medidata reported first quarter results that included revenues of $40.8 million, an 8% increase. Gross margins were also on the rise and are now at 68%. Coupling higher revenues with wider margins led to net income of $7.2 million, up $0.5 million. Earnings per share came out to $0.14, which was 3 cents lighter than expected. Despite the miss analysts still raised estimates for the full-year. The Zacks Consensus Estimate for 2011 rose 3 cents, to $1.13. Next year's average projection is also up 3 cents, to $1.25. In 2010 Medidata earned $1.01 per share, putting expected growth rates at 12% this year and 11% in 2012. M&A Activity Medidata announced that it...

GKN (LON:GKN), the engineering group, said this morning that it had signed an agreement with the shareholders of Germany’s Stromag Holding GmbH to acquire the business. The move will bolster GKN’s Land Systems division which was set up last summer to service customers in the off-highway market and pursue growth opportunities in high speed rail, renewable energy and defence. Stromag is a market leading engineer of industrial power management components. Its main products include hydraulic clutches, electro-magnetic brakes and flexible couplings serving end-markets including agricultural equipment, construction and mining machinery, renewable energy and the metal processing industry. The business is based in Unna, Germany and has operations in Germany, France, US, Brazil, India and China. GKN is paying €164 million (£146 million) in cash from existing resources for the equity and repayment of debt of €31 million (£28 million). Stromag is being acquired from shareholders including private equity firm Equita and a large number of other organisations and individuals, including management. In...

Shares of Vical Incorporated (Nasdaq:VICL) jumped +7.21% to $4.61 on Friday and continue to show some firepower following news that it has granted a global license to Japan's Astellas Pharma Inc. (TOKYO:4503). At the end of last week, both companies announced that they have signed exclusive license agreements for the United States and for all territories in the rest of world outside the United States to develop and commercialize TransVax(TM), Vical's therapeutic vaccine designed to control cytomegalovirus (CMV) reactivation in transplant recipients. The companies expect to begin a multinational Phase 3 registration trial of TransVax in hematopoietic stem cell transplant (HSCT) recipients as well as a Phase 2 trial in solid organ transplant (SOT) recipients in the first half of 2012. The companies expect to begin a multinational, Phase 3 registration trial of the cytomegalovirus vaccine, dubbed TransVax, in certain stem-cell transplant recipients. They also plan a Phase 2 trial in solid organ transplant recipients in the first half of next year. Cytomegalovirus...

Below are the top large-cap investment brokerage-national stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at TD Ameritrade Holding Corporation (NASDAQ: AMTD) is 15.23%. AMTD's operating margin for the same period is 36.78%. The trailing-twelve-month return on equity at Charles Schwab Corporation (The) (NYSE: SCHW) is 11.37%. SCHW's revenue for the same period is $4.48 billion. The trailing-twelve-month return on equity at Morgan Stanley (NYSE: MS) is 7.42%. MS' PEG ratio is 1.53. The trailing-twelve-month return on equity at CME Group Inc (NASDAQ: CME) is 5.83%.